Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve thienoindole synthesis challenges with nickel-catalyzed route: 96% yield, no strong acids, simplified purification. Scale to 100MT/yr with CDMO expertise.
Discover metal-free alpha-carboline synthesis with 99% yield. Eliminate transition metal residues and streamline your pharma supply chain. Contact us for custom production.
Solve high-cost synthesis challenges for 2,3-dihydroquinolone-based APIs. This patent's palladium-catalyzed method offers cheap raw materials, broad functional group tolerance, and scalable production. Reduce R&D time and supply chain risks.
Eliminate hazardous azide handling and metal catalysts in 5-trifluoromethyl triazole synthesis. Achieve 80%+ yields with scalable, cost-effective CDMO manufacturing.
Discover how one-pot copper-catalyzed synthesis of 2,3-disubstituted indolines reduces costs, eliminates intermediate purification, and ensures high yields for your pharmaceutical projects.
Solve high-cost, low-yield issues in 2-phenethylphenol synthesis. Our CDMO expertise delivers scalable, high-purity intermediates for antiplatelet drugs.
Solve high catalyst costs and low yields in triazole synthesis. Our CDMO expertise scales this bimetallic process for 92%+ purity, reducing your supply chain risks.
Discover a breakthrough chiral rhodium-catalyzed method for carbon-nitrogen axial chiral indole-naphthol compounds with 96%ee, mild conditions, and high yield. Reduce R&D costs and supply chain risks for your API synthesis.
Eliminate palladium catalysts and anhydrous conditions in vismodegib production. Achieve 99% purity with 50% yield using copper-catalyzed route. Reduce costs by 30%.
Eliminate heavy metal catalysts in 2-trifluoromethyl quinoline synthesis. Our metal-free, air-stable process reduces supply chain risks and costs for pharmaceutical intermediates.
Discover a metal-free, air-tolerant synthesis for trifluoroacetimide dihydrobenzofuran compounds. Eliminate heavy metal catalysts and nitrogen protection to reduce costs and improve supply chain reliability for pharmaceutical intermediates.
Solve hydrogenation and iron contamination issues in aminopyrimidine synthesis. Our CDMO expertise delivers high-yield, GMP-compliant production for non-small cell lung cancer therapeutics.
Discover a green, high-yield synthesis method for 4-oxo acrylate derivatives using visible light catalysis. Eliminate waste, reduce costs, and ensure supply chain stability for your pharmaceutical intermediates.
Solve high-cost, low-yield issues in isoquinolinone synthesis. Our CDMO expertise scales this copper-catalyzed method for 99% purity APIs and stable supply chains.
Solve aldehyde impurity challenges in progesterone production with this novel reductive amination method. Achieve 99.5% purity, 97% yield, and EU compliance without heavy metals.
Discover how nitrate hydrate-based synthesis of geminal dinitro compounds reduces costs, improves safety, and enables scalable production for drug development.
Reduce byproduct formation and improve yield to 52% with this one-step method. Ideal for API synthesis and supply chain stability in pharmaceutical manufacturing.
Solve toxic azide risks in triazole synthesis. New metal-free method offers 80%+ yields, safer production, and scalable manufacturing for API development.
Solve low stereoselectivity in α,β-unsaturated nitrile synthesis. New base-promoted method achieves >80% yield with cheap reagents. Scale to 100MT/yr.
Solve low enantioselectivity & high catalyst cost in alpha-hydroxy-beta-keto ester production. 97% ee, 95% yield, 5-25 mol% catalyst. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.